Membership: Join my YouTube channel membership and unlock exclusive perks! As a member, you'll get early access to videos to stay ahead with the latest content before anyone else. Investor tier members get access to my spreadsheets, and VIP discord members get access to our private discord community
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 07 Oct 2025, 01:01 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The analysis focuses on Kohl's (KSS). Management indicated satisfaction with results, though comparable sales decreased by 4.2%. Adjusted earnings per share were $0.56, exceeding expectations. Gross margin expanded by 30 basis points, with inventory lowered by 5% and SG&A expenses reduced by 4%. The analyst updated a discounted cash flow valuation, noting an increase in the company's intrinsic value due to decreased total debt and increased non-operating assets. This leads to an intrinsic value per share close to $26, while the current market price is $16.43. Based on the analysis, KSS stock is undervalued, leading to an upgrade in the analyst's rating to a "Buy" for the first time in 2025.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.